|

May 19, 2008
Helixis, Inc. Expands Management Team
Carlsbad, Calif., May 19, 2008
- Helixis, Inc., an early-stage company focused on
optimizing access to molecular analysis tools in research
and clinical diagnostics, today announced the addition of
three experienced marketing and development executives to
its management team. Judy Macemon has been named vice
president, marketing; Adrian Fawcett, senior director,
engineering; and Sameer Deepak Rohatgi, senior director,
business development.
"Judy, Adrian, and Sameer will
play critical roles at Helixis, particularly as we complete
development and begin commercialization of our first
research instrument," said Alex Dickinson, president, chief
executive officer and co-founder, Helixis, Inc. "Our ability
to attract this caliber of talent reflects both the rapid
progress we've made to date and the promise of our vision
for the evolution of real-time PCR."
Judy Macemon has an extensive
track record as a senior executive responsible for strategic
marketing and product commercialization in life science
research and clinical diagnostics companies. Her previous
experience includes national and global business and
marketing positions at Invitrogen, Stratagene (acquired by
Agilent), Agilent, Accelerys, Chromagen, Becton Dickinson
and Company, and MicroProbe Corporation. At Stratagene, Ms.
Macemon led the launch and commercialization of the
company's real-time PCR instrument portfolio. She also
served as director of technical services for the Diagnostics
Division of Baxter Healthcare and managed the clinical
laboratory for Group Health Cooperative in Seattle. Ms.
Macemon began her career working in hospital, clinical
reference and academic research laboratories. She earned a
BS degree in medical technology from Louisiana State
University, an MS in clinical microbiology from Texas
Women's University, and an MBA from San Diego State
University.
Adrian Fawcett has 20 years of
product development experience in scientific instruments and
systems. Over nearly a decade at Applied BioSystems, most
recently as director of R&D, Singapore Operations, Mr.
Fawcett led multiple development teams and worked
extensively with next-generation real-time PCR systems and
related technologies. Earlier, he held R&D management
positions with PEBiosciences and Perkin-Elmer, where he
focused on development of nucleic acid analysis tools. Mr.
Fawcett holds a Physics BSc (Hons) degree from Lancaster
University, UK.
Sameer Deepak Rohatgi brings
significant experience in global marketing, business
development, and commercialization of life science tools and
molecular diagnostics to Helixis. He held several positions
in the Life Science and Chemical Analysis division of
Agilent Technologies, including strategic planning for the
$1.9 billion business. Most recently, he served as Associate
Director, Genomics Marketing where he led the commercial
introduction of novel genetic and epigenetic microarray
assays that achieved over 20% year over year growth.
Earlier, he filled strategic marketing and project
management roles at Incyte. He began his career as a
management consultant with Ernst & Young LLP. Mr. Rohatgi
earned a BSE in biomedical engineering from Duke University,
an MS in biomedical engineering from Case Western Reserve
University, and an MBA from the George L. Graziadio School
at Pepperdine University.
About Helixis, Inc.
Helixis, Inc., with headquarters in Carlsbad, CA, is a
privately-held developer of innovative nucleic acid analysis
tools for research and clinical diagnostics. The Company was
founded in 2007 by a unique collaboration between molecular
biologists and engineers to pursue technologies discovered
in the labs of Nobel Laureate David Baltimore, PhD, and Axel
Scherer, PhD, at the California Institute of Technology.
Helixis is currently focused on delivering a new generation
of high-performance, compact, easy-to-use, and low-cost
"personal" real-time polymerase chain reaction (qPCR)
systems to the life science research community. More
information about Helixis is available at www.helixis.com.

|
 |